RaQualia Pharma's large shareholding report information has been updated. As of 2026/01/29, the individual's holding was 9.17%, while H.K. Inoen Corporation's holding changed to 15.94%. The scheduled earnings announcement date and previous change reports are also listed.
RaQualia Pharma's large shareholding report information has been updated. In the report dated 29 January 2026, the individual changed the holding ratio to 9.17%, with 2,384,700 shares held.
The report dated the same day shows H.K. Inoen Corporation changing its holding ratio to 15.94%, with 4,148,000 shares held.
Previous reports state that, on 12 December 2025, the individual held 9.75% and H.K. Inoen Corporation held 10.60%. On 18 April 2025, the individual's holding ratio was corrected to 9.76%.
The scheduled earnings announcement date is listed as 2026/11/13 in the “Scheduled Earnings Announcement Date” field on RaQualia Pharma's company information page.
The article also includes PDF links for major shareholders and data from previous change reports, organizing changes in the latest and historical holdings.